Cafferty, Fay H <br/><br/>
Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide and cisplatin in poor prognosis germ cell tumours: A randomised phase II trial (ISRCTN53643604).  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  03 2020 
 - 139-149 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-0852 
<br/><br/><label>Standard No.: </label>10.1016/j.ejca.2019.12.028  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bleomycin--administration & dosage<br/>Carboplatin--administration & dosage<br/>Cisplatin--administration & dosage<br/>Etoposide--administration & dosage<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--drug therapy<br/>Neoplasms, Germ Cell and Embryonal--drug therapy<br/>Prognosis<br/>Survival Rate<br/>Vincristine--administration & dosage<br/>Young Adult